Masood Ayyub Ghori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Masood Ayyub Ghori has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Abdulmajeed Al Zubaidi
Cardiac Science Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
1 shared publicationAdnan Al Nassir
Cardiac Science Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
1 shared publicationAwatif Al Sousi
Department of Cardiac Sciences, Adult Cardiology Department, Sheikh Khalifa Medical City, Abu Dhabi
1 shared publication- Moataz Ayman
Department of Cardiac Sciences, Cardiac Surgery Department, Sheikh Khalifa Medical City, Abu Dhabi
1 shared publication Moataz Ayman Abdelaziz
Cardiac Science Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
1 shared publicationNicolas Patrick Turrin
Quality Division, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 18 February 2013
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 25 (2) , 85-89
A case report of a right ventricular mass in a patient with Behçet’s disease: Myxoma or thrombus?
Introduction: Behçet’s disease (BD) is a multi-system, chronic and relapsing disorder classified as “vasculitic syndrome”. It typically affects young adult females between 20 and 40 years of age. There are some typical clinical manifestations associated with this disease, however, at times; rare sign and symptoms pose a challenge to the treating physician and making a definitive diagnosis. Presentations with cardiac symptoms are one of the extremely rare manifestations of the Behçet’s disease. Methods: The authors present clinical, laboratory and imaging findings of a patient who presented with a cardiac mass which was the first presenting feature or manifestation of Behçet’s disease. Results: A 19-year-old boy was admitted to our hospital for the investigation of “fever of unknown origin”, weight loss, shortness of breath and a scrotal ulcer of recent on-set. X-ray chest and electrocardiograms were inconclusive. Transthoracic echocardiography revealed a right ventricular (RV) mass attached to the interventricular septum measuring 1.5 × 1.5 cms (Panel A). Cardiac MRI identified it as a RV Myxoma. In addition, on CT scan of the chest pulmonary embolism was noted. The patient underwent excision biopsy of the tumor under cardiopulmonary bypass via right atriotomy (Panel B). Histopathology of the mass described it as “an organizing thrombus with a few groups of interrupted myocardial fibers and some infiltration of lymphocytes and plasma cells”. Moreover his HLA typing was found positive for HLA-B51 (5). In view of the above findings and associated lesions, the patient was diagnosed as a case of Behçet’s disease. The medical management included immunosuppressant and anticoagulation. Conclusion: Behçet’s disease, even in the absence of the typical clinical features, should be considered in the differential diagnosis of right ventricular mass, especially when dealing with young adults from the Mediterranean basin and the Middle-East.
- 18 February 2013
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 25 (2) , 85-89
Open AccessA case report of a right ventricular mass in a patient with Behçet’s disease: Myxoma or thrombus?
Introduction: Behçet’s disease (BD) is a multi-system, chronic and relapsing disorder classified as “vasculitic syndrome”. It typically affects young adult females between 20 and 40 years of age. There are some typical clinical manifestations associated with this disease, however, at times; rare sign and symptoms pose a challenge to the treating physician and making a definitive diagnosis. Presentations with cardiac symptoms are one of the extremely rare manifestations of the Behçet’s disease. Methods: The authors present clinical, laboratory and imaging findings of a patient who presented with a cardiac mass which was the first presenting feature or manifestation of Behçet’s disease. Results: A 19-year-old boy was admitted to our hospital for the investigation of “fever of unknown origin”, weight loss, shortness of breath and a scrotal ulcer of recent on-set. X-ray chest and electrocardiograms were inconclusive. Transthoracic echocardiography revealed a right ventricular (RV) mass attached to the interventricular septum measuring 1.5 × 1.5 cms (Panel A). Cardiac MRI identified it as a RV Myxoma. In addition, on CT scan of the chest pulmonary embolism was noted. The patient underwent excision biopsy of the tumor under cardiopulmonary bypass via right atriotomy (Panel B). Histopathology of the mass described it as “an organizing thrombus with a few groups of interrupted myocardial fibers and some infiltration of lymphocytes and plasma cells”. Moreover his HLA typing was found positive for HLA-B51 (5). In view of the above findings and associated lesions, the patient was diagnosed as a case of Behçet’s disease. The medical management included immunosuppressant and anticoagulation. Conclusion: Behçet’s disease, even in the absence of the typical clinical features, should be considered in the differential diagnosis of right ventricular mass, especially when dealing with young adults from the Mediterranean basin and the Middle-East.
- Open Access
- 30 April 2011
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 23 (2) , 93-95
Tenecteplase in prosthetic mitral valve thrombosis
In the few reported cases of prosthetic mitral valve thrombosis, where surgical intervention was considered as high risk, fibrinolytic therapy had proved life saving. The authors present clinical, laboratory, and imaging data from such a patient, with prosthetic mitral valve thrombosis and its successful management with tenecteplase. The use of tenecteplase as a viable fibrinolytic agent for the first time was justified, due to the lack of immunogenicity concerns compared to streptokinase.
- 30 April 2011
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 23 (2) , 93-95
Open AccessTenecteplase in prosthetic mitral valve thrombosis
In the few reported cases of prosthetic mitral valve thrombosis, where surgical intervention was considered as high risk, fibrinolytic therapy had proved life saving. The authors present clinical, laboratory, and imaging data from such a patient, with prosthetic mitral valve thrombosis and its successful management with tenecteplase. The use of tenecteplase as a viable fibrinolytic agent for the first time was justified, due to the lack of immunogenicity concerns compared to streptokinase.